Publication: Cervix Cancer Research Network (CCRN): Improving Access to Cervix Cancer Trials on a Global Scale
Issued Date
2016-11-01
Resource Type
ISSN
15251438
1048891X
1048891X
Other identifier(s)
2-s2.0-84994643796
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
International Journal of Gynecological Cancer. Vol.26, No.9 (2016), 1690-1693
Suggested Citation
David Gaffney, Bill Small, Henry Kitchener, Sang Young Ryu, Akila Viswanathan, Ted Trimble, Al Covens, Sarikapan Wilailak, Arb Aroon Lertkhachonsuk, Chomporn Sitathanee, Umesh Mahantshetty, Brandon Fisher, Susan Springer, Thomas Pollatz, Antonius Spiller, Monica Bacon, Anuja Jhingran Cervix Cancer Research Network (CCRN): Improving Access to Cervix Cancer Trials on a Global Scale. International Journal of Gynecological Cancer. Vol.26, No.9 (2016), 1690-1693. doi:10.1097/IGC.0000000000000823 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/41071
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Cervix Cancer Research Network (CCRN): Improving Access to Cervix Cancer Trials on a Global Scale
Other Contributor(s)
University of Utah
Loyola University of Chicago
University of Manchester
Korea Cancer Center Hospital
Johns Hopkins University
National Cancer Institute
Sunnybrook Health Sciences Centre
Mahidol University
Tata Memorial Hospital
Radiating Hope
Elekta Brachytherapy
Varian Medical Systems
BEBIG
Gynecological Cancer InterGroup
University of Texas MD Anderson Cancer Center
Loyola University of Chicago
University of Manchester
Korea Cancer Center Hospital
Johns Hopkins University
National Cancer Institute
Sunnybrook Health Sciences Centre
Mahidol University
Tata Memorial Hospital
Radiating Hope
Elekta Brachytherapy
Varian Medical Systems
BEBIG
Gynecological Cancer InterGroup
University of Texas MD Anderson Cancer Center
Abstract
Copyright © 2016 by IGCS and ESGO. Eighty-seven percent of cervix cancer occurs in less-developed regions of the world, and there is up to an 18-fold difference in mortality rate for cervix cancer depending on the region of the world. The Cervix Cancer Research Network (CCRN) was founded through the Gynecologic Cancer InterGroup with the aim of improving access to clinical trials in cervix cancer worldwide, and in so doing improving standards of care. The CCRN recently held its first international educational symposium in Bangkok. Sixty-two participants attended from 16 different countries including Pakistan, India, Bangladesh, Thailand, Malaysia, Singapore, Philippines, Taiwan, China, Vietnam, Korea, Japan, Columbia, Brazil, Canada, and the United States. The focus of this symposium was to evaluate progress, to promote new clinical trials for the CCRN, and to provide education regarding the role of brachytherapy in the treatment of cervical cancer.